Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial
2019
Diagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis
2021 Standout
The role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liver
2013
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia
2015
Mastery learning of thoracentesis skills by internal medicine residents using simulation technology and deliberate practice
2008
Prevalence and Control of Diabetes in Chinese Adults
2013 Standout
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
The Role of Cholesterol in the Pathogenesis of NASH
2015
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial
2017
COVID-19: A promising cure for the global panic
2020 Standout
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
2012
An assessment by the Statin Liver Safety Task Force: 2014 update
2014
Statin use and non-alcoholic steatohepatitis in at risk individuals
2015
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Non-alcoholic fatty liver disease
2021 Standout
Does Simulation-Based Medical Education With Deliberate Practice Yield Better Results Than Traditional Clinical Education? A Meta-Analytic Comparative Review of the Evidence
2011 Standout
The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease
2012
Automated detection of moderate and large pneumothorax on frontal chest X-rays using deep convolutional neural networks: A retrospective study
2018
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Use of simulation‐based mastery learning to improve the quality of central venous catheter placement in a medical intensive care unit
2009
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
The global NAFLD epidemic
2013 Standout
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
2012
Simulation in healthcare education: A best evidence practical guide. AMEE Guide No. 82
2013 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Dietary α-tocopherol and atorvastatin reduce high-fat-induced lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs
2014
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
2014
Bacillus amyloliquefaciens SC06 Protects Mice Against High-Fat Diet-Induced Obesity and Liver Injury via Regulating Host Metabolism and Gut Microbiota
2019
A critical review of simulation‐based medical education research: 2003–2009
2009 Standout
NAFLD: A multisystem disease
2015 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Chronic Kidney Disease
2016 Standout
The Utility of Simulation in Medical Education: What Is the Evidence?
2009 Standout
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
2006
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH
2021
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Antioxidants as therapeutic agents for liver disease
2011
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Pharmacotherapy for Nonalcoholic Fatty Liver Disease
2015
Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease
2012
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Simulation-based education with mastery learning improves residents' lumbar puncture skills
2012
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Central Line Simulation: A New Training Algorithm
2007
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Dapagliflozin in Patients with Chronic Kidney Disease
2020 Standout
The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
2020 Standout
Works of Craig E. Gordon being referenced
Beyond the Comfort Zone: Residents Assess Their Comfort Performing Inpatient Medical Procedures
2006
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
2010
Bleeding Complications of Native Kidney Biopsy: A Systematic Review and Meta-analysis
2012
Cisplatin, Cytarabine, Caffeine, and Continuously Infused 5-Fluorouracil (PACE) in the Treatment of Advanced Pancreatic Carcinoma
2000
Interferon Treatment in Hemodialysis Patients With Chronic Hepatitis C Virus Infection: A Systematic Review of the Literature and Meta-analysis of Treatment Efficacy and Harms
2008
Pneumothorax Following Thoracentesis
2010